What payment methods are accepted?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Is the product quality guaranteed?

Yes, we have ISO9001 and ISO13485 certifications and perform 100% inspection on finished products.

Sft Special Cleaning Solution for Succeeder Coagulation Analyzer of Sf Series

Name: Sft Special Cleaning Solution for Succeeder Coagulation Analyzer of Sf Series
Brand: Zhejiang Xinke Medical Technology Co., Ltd.
SKU: 2158914745

Zhejiang, ChinaZhejiang Xinke Medical Technology Co., Ltd.

US$1.00

1 Piece

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Reagent

Transport Package

Carton

Model NO.

JXK-407

Specification

10ml

Trademark

xinke

Origin

China

HS Code

3822190090

Production Capacity

500000/Ctns

Key features

Full Analyzer Compatibility: 100% compatible with Succeeder SF Series and Werfen ACL-TOP Series coagulation analyzers.

Flexible Customization: Offers flexible customization options to meet specific client requirements.

ISO Certified Quality: Manufacturing process certified under ISO9001:2015 and ISO13485 standards.

Comprehensive Inspection: 100% visual and functional inspection performed on all finished products.

Rapid Lead Time: Average lead time within 15 workdays for both peak and off-peak seasons.

Low MOQ: Minimum Order Quantity is just 1 piece, suitable for small-scale testing.

Established Manufacturer: Specialized in IVD reagents since 2004 with 16 R&D engineers.

Multiple Payment Options: Accepts LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Company profile

Importers and ExportersYears of Export Experience

Zhejiang Xinke Medical Technology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Flexible customization CertifiedExport Year: 20 Years CertifiedNearest Port: Ningbo PortAverage Response Time: ≤2.89h

AI-Powered supplier vetting

SummaryThe supplier operates in the clinical in vitro diagnostic reagent field and reports ten years of ISO9001 and ISO13485 quality-system certification. It offers flexible customization, has OEM experience with well-known brands, possesses self-managed import/export rights, and has exported for 20 years, with exports representing 51%–70% of total sales. Quality inspection procedures are documented and consistently followed, while stated lead times are within 15 working days in both peak and off-season. However, the supplier reports no inventory, overseas warehouse, overseas showroom, overseas agents or branches, offline trade-show participation, ODM service, SDK, recent new-product development, ERP, OA, CRM, SAP, or broader digitalization initiatives. Financial information is inconsistent or insufficiently interpretable in the provided records, so financial credibility cannot be determined.

Supplier typeThe supplier identifies itself as a company in the clinical in vitro diagnostic reagent field and has self-managed import/export rights with 20 years of export experience. This supports classification as an export-capable manufacturer or supplier in the medical in vitro diagnostics sector.

CertificationsThe company states that it has maintained ISO9001 and ISO13485 quality-system certifications for ten years. These explicitly documented certifications support a positive assessment of its quality-system credentials.

R&D capabilityThe supplier reports no new products in the past year, no ODM service, no available SDK, and no current enterprise digitalization or technical-transformation plan. These explicit limitations indicate weak demonstrated innovation capability.

Customization capabilityThe supplier explicitly provides flexible customization through both its R&D and design-service capabilities. This directly supports a positive assessment of customization capability, although ODM service is not offered.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of relevant customer experience. No specific brand names, project details, or verifiable case descriptions are provided, so the evidence is positive but limited.